How to buy BioLife Solutions stock

BioLife Solutions, Inc is a medical instruments & supplies business based in the US. BioLife Solutions shares (BLFS) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in BioLife Solutions

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for BioLife Solutions. Find the stock by name or ticker symbol: BLFS. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until BioLife Solutions reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of BioLife Solutions, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of BioLife Solutions. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

BioLife Solutions share price

Use our graph to track the performance of BLFS stocks over time.

BioLife Solutions shares at a glance

• Key figures

Information last updated 2020-10-20.

52-week range	USD$7.37 - USD$30.27
50-day moving average	USD$26.432
200-day moving average	USD$18.8633
Wall St. target price	USD$32.83
PE ratio	38.1944
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$0.58

Buy BioLife Solutions shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy BioLife Solutions stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of BioLife Solutions, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is BioLife Solutions under- or over-valued?

Valuing BioLife Solutions stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of BioLife Solutions's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

BioLife Solutions's P/E ratio

BioLife Solutions's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 38x. In other words, BioLife Solutions shares trade at around 38x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

BioLife Solutions's PEG ratio

BioLife Solutions's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 39.2857. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into BioLife Solutions's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

BioLife Solutions's EBITDA

BioLife Solutions's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$2.9 million.

The EBITDA is a measure of a BioLife Solutions's overall financial performance and is widely used to measure a its profitability.

BioLife Solutions financials

Revenue TTM	USD$37 million
Gross profit TTM	USD$18.9 million
Return on assets TTM	-0.75%
Return on equity TTM	25.22%
Profit margin	51.86%
Book value	$4.074
Market capitalisation	USD$898.3 million

TTM: trailing 12 months

Shorting BioLife Solutions shares

There are currently 1.7 million BioLife Solutions shares held short by investors – that's known as BioLife Solutions's "short interest". This figure is 34.3% up from 1.3 million last month.

There are a few different ways that this level of interest in shorting BioLife Solutions shares can be evaluated.

BioLife Solutions's "short interest ratio" (SIR)

BioLife Solutions's "short interest ratio" (SIR) is the quantity of BioLife Solutions shares currently shorted divided by the average quantity of BioLife Solutions shares traded daily (recently around 428863). BioLife Solutions's SIR currently stands at 4. In other words for every 100,000 BioLife Solutions shares traded daily on the market, roughly 4000 shares are currently held short.

However BioLife Solutions's short interest can also be evaluated against the total number of BioLife Solutions shares, or, against the total number of tradable BioLife Solutions shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case BioLife Solutions's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 BioLife Solutions shares in existence, roughly 50 shares are currently held short) or 0.0705% of the tradable shares (for every 100,000 tradable BioLife Solutions shares, roughly 71 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against BioLife Solutions.

Find out more about how you can short BioLife Solutions stock.

BioLife Solutions share dividends

We're not expecting BioLife Solutions to pay a dividend over the next 12 months.

Have BioLife Solutions's shares ever split?

BioLife Solutions's shares were split on a 1:14 basis on 29 January 2014. So if you had owned 14 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BioLife Solutions shares – just the quantity. However, indirectly, the new 1300% higher share price could have impacted the market appetite for BioLife Solutions shares which in turn could have impacted BioLife Solutions's share price.

BioLife Solutions share price volatility

Over the last 12 months, BioLife Solutions's shares have ranged in value from as little as $7.37 up to $30.27. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioLife Solutions's is 1.4424. This would suggest that BioLife Solutions's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

BioLife Solutions overview

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools for the cell and gene therapy industry in North America, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; and liquid nitrogen laboratory freezers, cryogenic equipment, and accessories. The company markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington.

Frequently asked questions

• What percentage of BioLife Solutions is owned by insiders or institutions?

  Currently 27.02% of BioLife Solutions shares are held by insiders and 58.073% by institutions.

• When does the fiscal year end for BioLife Solutions?

  BioLife Solutions's fiscal year ends in December.

• Where is BioLife Solutions based?

  BioLife Solutions's address is: 3303 Monte Villa Parkway, Bothell, WA, United States, 98021

• What is BioLife Solutions's ISIN number?

  BioLife Solutions's international securities identification number is: US09062W2044

• What is BioLife Solutions's CUSIP number?

  BioLife Solutions's Committee on Uniform Securities Identification Procedures number is: 09062W105